101 related articles for article (PubMed ID: 23769051)
1. Plasticity and overlap of in vitro-induced regulatory T-cell markers in healthy humans.
Wang H; Daniel V; Sadeghi M; Opelz G
Transplant Proc; 2013 Jun; 45(5):1816-21. PubMed ID: 23769051
[TBL] [Abstract][Full Text] [Related]
2. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
Wang H; Daniel V; Sadeghi M; Opelz G
Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
[TBL] [Abstract][Full Text] [Related]
3. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
[TBL] [Abstract][Full Text] [Related]
4. In-vitro inhibition of IFNγ+ iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function.
Daniel V; Sadeghi M; Wang H; Opelz G
BMC Immunol; 2012 Aug; 13():47. PubMed ID: 22905732
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
[TBL] [Abstract][Full Text] [Related]
6. IFNγ+ Treg in-vivo and in-vitro represent both activated nTreg and peripherally induced aTreg and remain phenotypically stable in-vitro after removal of the stimulus.
Daniel V; Trojan K; Adamek M; Opelz G
BMC Immunol; 2015 Aug; 16():45. PubMed ID: 26268522
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)CD25(+)Foxp3(+)IFNγ(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC.
Daniel V; Sadeghi M; Wang H; Opelz G
Transpl Immunol; 2012 Oct; 27(2-3):114-21. PubMed ID: 22954802
[TBL] [Abstract][Full Text] [Related]
8. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
[TBL] [Abstract][Full Text] [Related]
9. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
10. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
[TBL] [Abstract][Full Text] [Related]
12. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
[TBL] [Abstract][Full Text] [Related]
13. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
14. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
15. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
16. CD26: a negative selection marker for human Treg cells.
Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M
Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266
[TBL] [Abstract][Full Text] [Related]
17. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
[TBL] [Abstract][Full Text] [Related]
18. [Influence of anti-ICOS antibody on quantity and function of CD4(+);CD25(+);Foxp3(+);Treg from lymph and blood of rats with bronchial asthma].
Zhao L; Feng XB; Wang YS; Cui QQ; Cao YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1029-32. PubMed ID: 23046932
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of CD4(+)CD25(+)CD127(low/-) Treg cells in mice].
Liu HY; Ma LP; Wei J; Ouyang XF; Luo XM; Gao YM; Chang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1469-73. PubMed ID: 23257455
[TBL] [Abstract][Full Text] [Related]
20. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
